Copeptin, miRNA-208, and miRNA-499 as New Biomarkers for Early Detection of Acute Coronary Syndrome.

Gaber, Marwa A; Omar, Omnia H M; El-Deek, Sahar E M; Hassan, Ayman K M; Mahmoud, Marwan S; Meki, Abdel-Raheim M A

Gaber, Marwa A; Omar, Omnia H M; El-Deek, Sahar E M; Hassan, Ayman K M; Mahmoud, Marwan S; Meki, Abdel-Raheim M A.

Afiliação

Gaber MA; Medical Biochemistry Department, Faculty of Medicine, Assiut University, Assiut, Egypt. Marwagaber@aun.edu.eg.
Omar OHM; Assiut International Center of Nanomedicine, El-rajhy liver Hospital, Assiut University, Assiut, Egypt.
El-Deek SEM; Medical Biochemistry Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
Hassan AKM; Cardiology Department, Faculty of Medicine,, Assiut University, Assiut, Egypt.
Mahmoud MS; Cardiology Department, Faculty of Medicine,, Assiut University, Assiut, Egypt.
Meki AMA; Medical Biochemistry Department, Faculty of Medicine, Assiut University, Assiut, Egypt.

Appl Biochem Biotechnol ; 194(3): 1193-1205, 2022 Mar.

Article em En | MEDLINE | ID: mdl-34637111

Assuntos

Glicopeptídeos

Palavras-chave

Acute coronary syndrome; Copeptin; Non-ST-segment elevation Myocardial infarction; Unstable angina; miRNA-208; miRNA-499

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicopeptídeos Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Appl Biochem Biotechnol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google